Protein electrophoresis

ALSO KNOWN AS: Serum protein electrophoresis (SPEP)

DEFINITION: Protein electrophoresis is a laboratory test used to measure the amounts of major proteins in a patient’s blood serum, urine, or cerebrospinal fluid.

Cancers diagnosed: Most metastatic cancers, especially multiple myeloma, lymphoma, chronic lymphocytic leukemia

94462398-95158.jpg94462398-95195.jpg

Why performed: Serum protein electrophoresis is used to screen for cancer or evaluate the extent of an existing cancer, particularly multiple myeloma. It can also be used to identify other diseases, including kidney, liver, intestinal, and immune disorders, as well as malnutrition. These disorders are associated with abnormal levels of different blood proteins, which can be detected by electrophoresis.

Patient preparation: There is no special preparation for this procedure. Patients undergo a normal fasting blood test (meaning that they cannot eat or drink for about twelve hours prior) and should tell their physicians which prescription medications they are taking.

Steps of the procedure: A physician or nurse will draw blood from a vein in the patient’s arm in an outpatient setting. The blood sample is transferred to the laboratory, where it is centrifuged to separate serum, the plasma without clotting factors, from the blood cells. Blood proteins are retained in the serum. A small amount of serum is then transferred to an electrophoretic paper or gel, such as cellular acetate or agarose, respectively. Since proteins are charged molecules and vary in size, they will migrate differentially when a current is applied to the electrophoretic field. A fluorescent agent that binds to proteins is added to the serum for illumination. The result is a gradient of separated bands, or fractions, of proteins. A laboratory specialist studies an image of the gel to determine the relative concentrations of different proteins in the blood serum.

In the twenty-first century, advances have been made that have improved protein electrophoresis. Automated capillary electrophoresis systems have made the analysis of protein mixtures more accurate. Capillary gel electrophoresis has made separating proteins easier, allowing for precise analysis. Microchip electrophoresis and two-dimensional electrophoresis have also seen significant improvements. Finally, capillary zone electrophoresis (CZE) is an alternative to protein electrophoresis. CZE is seen by many in the medical community as more accurate, sensitive, and faster. 

After the procedure: A bandage is applied to the patient’s arm at the puncture site, and the patient can go home.

Risks: Protein electrophoresis does not carry risks. However, a blood draw may cause minor bleeding or bruising at the puncture site. The patient may also feel light-headed, and fainting is possible after the blood draw.

Results: The major blood proteins consist of albumin and globulins. There are four types of globulin proteins: alpha-1 globulins, alpha-2 globulins, beta globulins, and gamma globulins. Albumin makes up more than half of the proteins in the blood serum and is essential for normal tissue growth. High levels of albumin proteins result from dehydration, while low levels suggest inflammatory disease, liver disease, malnutrition, or a kidney disorder. High levels of alpha-1 globulins (alpha-1 antitrypsin, thyroid-binding globulin, and transcortin) may indicate acute inflammatory disease and malignancies, while a low level can indicate liver disease. The levels of certain alpha-2 globulins (ceruloplasmin, alpha-2 macroglobulin, and haptoglobulin) can aid in cancer diagnosis. For example, a low level of haptoglobin may indicate tumor metastasis or liver disease. Variations in other alpha-2 globulin levels may indicate inflammation, nephrotic syndrome, or hemolysis, which is the loss of hemoglobin from red blood cells. High levels of beta globulin (transferrin and beta lipoprotein) can indicate cirrhosis, hyperthyroidism, diabetes mellitus, and carcinoma in some cases, while decreased levels indicate malnutrition. High levels of gamma globulins (various antibodies) are the most indicative of cancers such as multiple myeloma, lymphocytic leukemia, or malignant lymphoma. In addition, high levels can indicate Hodgkin's disease, connective tissue disorders, and chronic or acute infections. A patient whose serum protein electrophoresis yields abnormal results will be referred to a hematologist-oncologist.

Bibliography

Acevedo, Aaron. “Capillary Gel Electrophoresis of Proteins: Past and Present Advances.” Chromatography Online, 19 Apr. 2023, www.chromatographyonline.com/view/capillary-gel-electrophoresis-of-proteins-past-and-present-advances. Accessed 25 June 2024.

“Agilent Announces New ProteoAnalyzer System.” Agilent, 16 Jan. 2024, www.agilent.com/about/newsroom/presrel/2024/16jan-ca23042.html. Accessed 25 June 2024.

Aziz, Khalid, and George Y. Wu. Cancer Screening: A Practical Guide for Physicians. Totowa: Humana, 2002.

Bossuyt, Xavier. “Advances in Serum Protein Electrophoresis.” Advances in Clinical Chemistry, vol. 42, 2006, pp. 43-80, doi:10.1016/s0065-2423(06)42002-3.

Hoffman, Ronald, et al. Hematology: Basic Principles and Practice. 6th ed., Philadelphia: Elsevier, 2013.

Jolliff, C R, and C R Blessum. “Comparison of Serum Protein Electrophoresis by Agarose Gel and Capillary Zone Electrophoresis in a Clinical Setting.” Electrophoresis, vol. 18.10, 1997, pp. 1781-4, doi:10.1002/elps.1150181012.

Keren, David F. High-Resolution Electrophoresis and Immunofixation: Techniques and Interpretation. 2nd ed., Boston: Butterworth, 1994.

Leukemia and Lymphoma Society. Understanding Lab and Imaging Tests. White Plains: Leukemia and Lymphoma Soc., 2012.

O’Connell, T. X., et al. “Understanding and Interpreting Serum Protein Electrophoresis.” American Family Physician, vol. 71.1, 2005, pp. 105–12.

“Protein Electrophoresis - Serum.” MedlinePlus, 25 Jan. 2022, medlineplus.gov/ency/article/003540.htm. Accessed 25 June 2024.

Williamson, Mary A., and L. Michael Snyder. Wallach's Interpretation of Diagnostic Tests. 10th ed., Philadelphia: Lippincott, 2011.